Bite Ninja is modernizing and digitizing food service order-taking, starting with US drive-throughs
Bite Ninja has created a gig economy marketplace for restaurants to address the massive and ongoing labor shortage while providing employees with a safe and competitively-compensated position. Working primarily with restaurant drive-through operations, Bite Ninja provides business owners and managers with plug-and-play software and a pool of qualified, trained and vetted freelancers to take customer orders remotely. Meanwhile, workers have the opportunity to plan their work schedules and choose from shifts all across the country, which yield above average pay. Starting with drive throughs, Bite Ninja is modernizing and digitizing order-taking throughout the service industry.
Will Clem’s family has been in the restaurant industry for three generations. Bite Ninja was built and developed in his Baby Jack’s restaurant chain. Will has been a visionary entrepreneur since the day he entered the business world and was a scientific co-founder and the “Memphis” of Memphis Meats. He brings a unique combination of vision, scientific method, and tech knowledge to the team at Bite Ninja. Will holds a PhD in Biomedical Engineering and an MBA, both from the University of Alabama at Birmingham.
Orin Wilson is a thought leader in his field, having started and grown a variety of business service companies both in the US and abroad. He is also considered an expert on outsourced technical labor markets and how to implement solid strategy for organizations to utilize those markets. Being an operational and financial systems specialist, Orin brings his experience with systems, software, and strategy to the Bite Ninja team. Prior to Bite Ninja, Orin was CEO of C3 Consolidated. He is also a CPA and the President of the Institute of Management Accountants - Central Arkansas Chapter.
Ron Shigeta is a serial entrepreneur and startup biotech and foodtech pioneer. As Co-Founder & Chief Science Officer of IndieBio, Ron played a key role in kick starting “Startup Biotech” as we know it. During his tenure he led early stage efforts conducting 80+ investments in high potential startups across gene therapy, diagnostics, precision medicine and synthetic biology, amongst others. The portfolio today holds a total market value of $3.5B. Ron holds a PhD in Chemistry from Princeton University and held postdoctoral positions at Harvard University as well as Stanford University.